Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL.

Name: Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL.
Author: He, Xiaoyuan

Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL. — المؤلف: He, Xiaoyuan — Leukemia 20191028

المؤلف: He, Xiaoyuan
النشر: Leukemia 20191028
الوصف: 2102-2104 p.
الموضوعات: Adult؛ Central Nervous System Neoplasms؛ Humans؛ Precursor B-Cell Lymphoblastic Leukemia-Lymphoma؛ Receptors, Antigen, T-Cell؛ Recurrence